稳定性缺血性心脏病患者心血管疾病事件风险分布不均
基于丹麦西部心脏注册研究的21,275例有症状患者,利用CTA评估冠脉病变严重程度并结合传统危险因素建模预测5年心血管事件与死亡风险。中位随访4.2年发生1,295例事件,5年风险中位数4%(IQR 3%–8%),个体风险从<5%至>50%不等。冠脉病变严重程度是最强危险因素,但传统危险因素也显著贡献,不同CAD程度患者风险分布明显重叠。
要点
- 冠脉CTA所示病变严重程度是5年心血管事件与死亡的最强预测因素。
- 不同CAD严重程度患者风险分布大量重叠,广泛非阻塞性病变者风险可高于阻塞性病变者。
- 阻塞性CAD患者中12%的5年风险<10%,24%的5年风险>20%。
关键影像表现/征象
- 冠脉病变严重程度为最强风险因素,传统危险因素亦显著贡献风险。
- 不同CAD严重程度患者风险分布大量重叠,广泛非阻塞性CAD患者估计风险可高于阻塞性CAD(狭窄>50%)患者。
- 排除血运重建作为终点时,同样发现风险大量重叠。
诊断标准与关键数值
- 5年心血管事件(心肌梗死、血运重建、缺血性卒中)与死亡风险中位数4%(四分位距3%–8%),个体范围<5%至>50%。
- 阻塞性CAD(狭窄>50%)患者中12%的5年风险<10%,24%的5年风险>20%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The authors sought to assess the distribution of 5-year risk of cardiovascular disease (CVD) events (myocardial infarction, revascularizations, ischemic stroke) and death among symptomatic patients with varying degrees of coronary artery disease (CAD) ascertained from computed tomography angiography (CTA).
BACKGROUND: CTA is used increasingly as the first-line test for evaluating patients with symptoms suggestive of CAD. This creates the daily clinical challenge of best using the information available from CTA to guide appropriate downstream allocation of preventive treatments.
METHODS: Among 21,275 patients from the Western Denmark Heart Registry, the authors developed a model predicting 5-year risk for CVD and death based on traditional risk factors and CAD severity. Only events occurring >90 days after CTA were included.
RESULTS: During a median follow-up of 4.2 years, 1,295 CVD events and deaths occurred. The median 5-year risk for events was 4% (interquartile range: 3% to 8%), and ranged from <5% to >50% in individual patients. The degree of CAD severity was the strongest risk factor; however, traditional risk factors also contributed significantly to risk. Thus, risk distributions in patients with varying degree of CAD overlapped considerably, and patients with extensive nonobstructive CAD could have higher estimated risk than patients with obstructive CAD (stenosis >50%). Among patients with obstructive CAD, 12% had 5-year risk <10% whereas 24% had risk >20%. A similar large overlap in risk was found when revascularizations were excluded from the endpoint.
CONCLUSIONS: The 5-year risk for CVD events and death varies substantially in symptomatic patients undergoing CTA, even in the presence of obstructive CAD. These results provide support for individual risk assessment to improve potential benefit when allocating preventive therapies following CTA.
引用
- Mortensen MB, Steffensen FH, Bøtker HE, et al. Heterogenous Distribution of Risk for Cardiovascular Disease Events in Patients With Stable Ischemic Heart Disease. JACC Cardiovasc Imaging. 2020. PMID: 33221243. doi:10.1016/j.jcmg.2020.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。